Insider · CIK 0001923444
Jaime Sepulveda
Files at HLVX (HilleVax, Inc.). First filing -, latest -.
In brief
Jaime Sepulveda files SEC Form 4 as director at HLVX (HilleVax, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jaime Sepulveda has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2025 | HLVX HilleVax, Inc. | UTender of shares Common Stock | -59,224 | - | - | 0 | Sep 17, 2025 |
| Jun 23, 2025 | HLVX HilleVax, Inc. | AGrant or award Common Stock | +17,199 | $0.00 | $0 | 59,224 | Jun 25, 2025 |
| Jun 6, 2024 | HLVX HilleVax, Inc. | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Apr 30, 2025 |
Questions about Jaime Sepulveda
Answered from the filings on this page, as of the latest one.
Is Jaime Sepulveda buying or selling?
Jaime Sepulveda has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jaime Sepulveda's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jaime Sepulveda has 0.
Where does Jaime Sepulveda file Form 4?
Jaime Sepulveda has filed Form 4 at HLVX (HilleVax, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.